Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Clinica Belgica|September 16, 2024
A case of VEXAS with microcytic anemia: don't be mislead by an associated condition!Kenza Squalli, Louis Wolff, Frédéric Vandergheynst
European Journal of Case Reports in Internal Medicine|June 12, 2025
Nephrogenic Diabetes Insipidus Associated with Temozolomide Therapy in a Patient with Grade IV AstrocytomaZayd Fargouche, Martin Manderlier, Anne-Pascale Meert, et al.
Cells|November 27, 2024
Understanding Myelodysplasia and Inflammation Through the Lense of VEXAS Syndrome: A ReviewLouis Wolff, Leo Caratsch, Lin-Pierre Zhao, et al.
International Journal of Molecular Sciences|December 9, 2023
Polyarteritis Nodosa: Old Disease, New EtiologiesLouis Wolff, Alice Horisberger, Laura Moi, et al.
Revue Medicale Suisse|November 21, 2024
[What should be done in case of cutaneous sclerosis?]Louis Wolff, Christa-Maria Maniu, Carmen Orte Cano, et al.
Emerging Infectious Diseases|December 9, 2020
COVID-19-Associated Fusobacterium nucleatum Bacteremia, BelgiumLouis Wolff, Delphine Martiny, Véronique Yvette Miendje Deyi, et al.
The Oncologist|August 19, 2025
Acquired Hemophilia due to Immune Checkpoint Inhibitors: A Case Series Introducing Emicizumab TreatmentLouis Wolff, Carolin Ertl, Lucie Heinzerling, et al.
Critical Reviews in Oncology/Hematology|March 22, 2026
"When Immunity Backfires: meta-analysis on Sarcoidosis Reactivation in Cancer Patients Treated with Immune Checkpoint Inhibitors"Serafina Martella, Giacomo Cusumano, Dimitrios Stylianakis, et al.
Swiss Medical Weekly|March 25, 2025
VEXAS syndrome: a Swiss national retrospective cohort studyLouis Wolff, Leo Caratsch, Fabian Lötscher, et al.
Rheumatology (Oxford, England)|March 26, 2025
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre studyAdrien Cottu, Laure Delaval, Alexandra Forestier, et al.
Pageof 1